adenocarcinoma of the gallbladder
Showing 1 - 25 of 2,590
Poorly Differentiated Adenocarcinoma With Signet Ring Cells of
Completed
- Gallbladder Cancer
- laparoscopic whole-layer cholecystectomy
-
Ōita, Oita, Japanoita Red Cross hospital
Sep 24, 2022
Gallbladder Adenocarcinoma Trial in Morgantown (HIPEC)
Not yet recruiting
- Gallbladder Adenocarcinoma
-
Morgantown, West VirginiaWest Virginia University Cancer Institute Mary Babb Randolph Can
Jun 23, 2022
Extrahepatic Bile Duct Adenocarcinoma, Biliary Type, Gallbladder Adenocarcinoma, Biliary Type, Metastatic Pancreatic
Active, not recruiting
- Extrahepatic Bile Duct Adenocarcinoma, Biliary Type
- +27 more
- Durvalumab
- Guadecitabine
-
Los Angeles, California
- +2 more
Aug 5, 2022
Colon Adenocarcinoma, Rectal Adenocarcinoma, Gastric Adenocarcinoma Trial in Washington (Atezolizumab, Bevacizumab)
Not yet recruiting
- Colon Adenocarcinoma
- +6 more
-
Washington, District of ColumbiaGeorgetown Lombardi Comprehensive Cancer Center
Jul 28, 2022
Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Non-Resectable Cholangiocarcinoma Trial in Los
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- +15 more
- Cisplatin
- +6 more
-
Los Angeles, California
- +1 more
Aug 5, 2022
Investigate Rectal Mucus in Aero-Digestive Tract Cancer.
Recruiting
- Non Small Cell Lung Cancer
- +4 more
- Oricol Test
-
Exeter, United KingdomRoyal Devon & Exeter NHS Foundation Trust
Jan 24, 2023
Minimal Residual Disease, KRAS G12D, KRAS G12R Trial in United States (ELI-002 2P)
Recruiting
- Minimal Residual Disease
- +11 more
- ELI-002 2P
-
Duarte, California
- +10 more
Jan 18, 2023
Metastatic Cancer, Foregut Carcinoid Tumor, Gastric Adenocarcinoma Trial (drug, procedure, radiation, other)
Not yet recruiting
- Metastatic Cancer
- +7 more
- Standard of Care Chemotherapy
- +7 more
- (no location specified)
Apr 1, 2022
Distal Bile Duct Adenocarcinoma, Gallbladder Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Duarte (Cisplatin, Gemcitabine,
Suspended
- Distal Bile Duct Adenocarcinoma
- +7 more
- Cisplatin
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 8, 2022
Bile Duct Carcinoma, Gallbladder Carcinoma, Pancreatic Ductal Adenocarcinoma Trial in Houston (Endoscopic Retrograde
Recruiting
- Bile Duct Carcinoma
- +2 more
- Endoscopic Retrograde Cholangiopancreatography
-
Houston, TexasM D Anderson Cancer Center
Jul 10, 2022
Recurrent Biliary Tract Carcinoma, Recurrent Distal Bile Duct Adenocarcinoma, Recurrent Gallbladder Carcinoma Trial
Not yet recruiting
- Recurrent Biliary Tract Carcinoma
- +13 more
- Binimetinib
- +10 more
- (no location specified)
Nov 8, 2022
Metastatic Distal Bile Duct Adenocarcinoma, Metastatic Gallbladder Carcinoma, Metastatic Intrahepatic Cholangiocarcinoma Trial
Recruiting
- Metastatic Distal Bile Duct Adenocarcinoma
- +9 more
- Atezolizumab
- +6 more
-
Phoenix, Arizona
- +28 more
Dec 31, 2022
Acinar Cell Adenocarcinoma of the Pancreas, Adenocarcinoma of the Gallbladder, Adenocarcinoma of Unknown Primary Trial in
Completed
- Acinar Cell Adenocarcinoma of the Pancreas
- +39 more
- oxaliplatin
- +4 more
-
Chicago, Illinois
- +1 more
May 7, 2020
Gallbladder Cancer Trial in Varanasi (Everolimus 10 mg, Standard of care)
Recruiting
- Gallbladder Cancer
- Everolimus 10 mg
- Standard of care
-
Varanasi, UP, IndiaBanaras Hindu University
Apr 18, 2023
Adenocarcinoma of the Extrahepatic Bile Duct, Adenocarcinoma of the Gallbladder, Malignant Tumor Trial in Los Angeles, Houston
Terminated
- Adenocarcinoma of the Extrahepatic Bile Duct
- +6 more
- trastuzumab
- laboratory biomarker analysis
-
Los Angeles, California
- +1 more
Jul 29, 2019
Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen
Recruiting
- Acinar Cell Carcinoma
- +93 more
- Biospecimen Collection
- +2 more
-
Birmingham, Alabama
- +998 more
Aug 23, 2022
Gallbladder Cancer Trial in Varanasi (Next generation sequencing)
Recruiting
- Gallbladder Cancer
- Next generation sequencing
-
Varanasi, UP, IndiaBanaras Hindu University
Jun 2, 2022
Cancer Trial in United States (mAb RAV12)
Completed
- Cancer
- monoclonal antibody RAV12
-
Santa Monica, California
- +4 more
Feb 4, 2022
Pancreatic Cancer, Hepatocellular Cancer, Biliary Tract Cancer Trial in Edmonton (Durvalumab, Gemcitabine, Nab paclitaxel)
Not yet recruiting
- Pancreatic Cancer
- +3 more
- Durvalumab
- +5 more
-
Edmonton, Alberta, CanadaCross Cancer Institute
Feb 1, 2023
Cholangiocarcinoma Non-resectable, Cholangiocarcinoma, Intrahepatic, Cholangiocarcinoma, Extrahepatic Trial in Korea, Republic
Terminated
- Cholangiocarcinoma Non-resectable
- +3 more
- PEGPH20
- +3 more
-
Phoenix, Arizona
- +35 more
Jan 24, 2020
Pancreatic Cancer, Cholangiocarcinoma, Gallbladder Cancer Trial in Seoul (cell free DNA in blood and urine,
Recruiting
- Pancreatic Cancer
- +2 more
- cell free DNA in blood and urine, metabolite/microbiome in urine and stool
-
Seoul, Korea, Republic of
- +1 more
Nov 2, 2022
Pancreatic Ductal Adenocarcinoma Trial in Saint Louis (BMS-813160, Nivolumab, Gemcitabine)
Active, not recruiting
- Pancreatic Ductal Adenocarcinoma
- BMS-813160
- +5 more
-
Saint Louis, MissouriWashington University School of Medicine
Dec 8, 2022
Polyps Gallbladder Trial in China (Danning Tablet)
Not yet recruiting
- Polyps Gallbladder
- Danning Tablet
-
Zhengzhou, Henan, China
- +17 more
Dec 25, 2022
Management Strategy of Polypoid Lesions of the Gallbladder
Completed
- Polyp Gallbladder
- Non
-
Beijing, ChinaPeking Union Medical College Hospital
Feb 17, 2021